Schering-Plough cuts 10% amidst Vytorin woes
Days after cardiologists gave the company's key cholesterol products a pounding, Schering-Plough announced a sweeping cost-cutting plan designed to save $1.5 billion by 2012 through a 10% reduction in headcount starting with senior management and sales and marketing.
Your Email Address:
Recipient(s) Email Address:
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
Include a message (optional):
The e-mail address(es) that you supply to use this service will only be used to send the requested article.